[76Br]-8-(4-bromo-2-chlorophenyl)-N,N-bis(2-methoxyethyl)-2,7-dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine

ID: ALA1762817

PubChem CID: 10917602

Max Phase: Preclinical

Molecular Formula: C19H23BrClN5O2

Molecular Weight: 468.78

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COCCN(CCOC)c1nc(C)nc2c(-c3ccc([76Br])cc3Cl)c(C)nn12

Standard InChI:  InChI=1S/C19H23BrClN5O2/c1-12-17(15-6-5-14(20)11-16(15)21)18-22-13(2)23-19(26(18)24-12)25(7-9-27-3)8-10-28-4/h5-6,11H,7-10H2,1-4H3/i20-4

Standard InChI Key:  GQBIMIUJNCVMCR-BMILMZPDSA-N

Molfile:  

     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
   -3.9014    1.4542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9026    0.6268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1878    0.2140    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1896    1.8670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6174    0.2149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1920    2.6920    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4788    3.1066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7631    2.6962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0499    3.1109    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3342    2.7005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9077    3.1023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6210    2.6877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3367    3.0981    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0501    2.6834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6843    0.3715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1965    1.0432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6848    1.7147    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4742    1.4578    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4739    0.6277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3715    1.0435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2521   -0.3291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6915   -1.0287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3053   -1.7569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4800   -1.7867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0423   -1.0823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4309   -0.3570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0048    0.3436    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.0922   -2.5149    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  4  6  1  0
 13 14  1  0
 18 19  1  0
  3 19  1  0
  6  7  1  0
 16 17  2  0
  1  2  1  0
  7  8  1  0
 18  4  1  0
 15 16  1  0
 17 18  1  0
 19 15  2  0
  8  9  1  0
 16 20  1  0
  4  1  2  0
  9 10  1  0
 21 22  2  0
 22 23  1  0
  6 11  1  0
 23 24  2  0
  2  5  1  0
 24 25  1  0
 11 12  1  0
 25 26  2  0
 26 21  1  0
 15 21  1  0
  2  3  2  0
 26 27  1  0
 12 13  1  0
 24 28  1  0
M  ISO  1  28  76
M  END

Associated Targets(Human)

CRHR1 Tclin Corticotropin releasing factor receptor 1 (2996 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cortex (245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cerebellum (218 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.78Molecular Weight (Monoisotopic): 467.0724AlogP: 3.92#Rotatable Bonds: 8
Polar Surface Area: 64.78Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.63CX LogP: 4.46CX LogD: 4.46
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.50Np Likeness Score: -1.51

References

1. Zuev D, Mattson RJ, Huang H, Mattson GK, Zueva L, Nielsen JM, Kozlowski ES, Huang XS, Wu D, Gao Q, Lodge NJ, Bronson JJ, Macor JE..  (2011)  Potential CRF1R PET imaging agents: N-fluoroalkyl-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethyl-N-alkylpyrazolo[1,5-a][1,3,5]triazin-4-amines.,  21  (8): [PMID:21411322] [10.1016/j.bmcl.2011.02.050]
2. Deskus JA, Dischino DD, Mattson RJ, Ditta JL, Parker MF, Denhart DJ, Zuev D, Huang H, Hartz RA, Ahuja VT, Wong H, Mattson GK, Molski TF, Grace JE, Zueva L, Nielsen JM, Dulac H, Li YW, Guaraldi M, Azure M, Onthank D, Hayes M, Wexler E, McDonald J, Lodge NJ, Bronson JJ, Macor JE..  (2012)  [18F](R)-5-chloro-1-(1-cyclopropyl-2-methoxyethyl)-3-(4-(2-fluoroethoxy)-2,5-dimethyl phenylamino)pyrazin-2(1H)-one: introduction of N3-phenylpyrazinones as potential CRF-R1 PET imaging agents.,  22  (21): [PMID:23010264] [10.1016/j.bmcl.2012.08.112]
3. Denhart DJ, Zuev D, Ditta JL, Hartz RA, Ahuja VT, Mattson RJ, Huang H, Mattson GK, Zueva L, Nielsen JM, Kozlowski ES, Lodge NJ, Bronson JJ, Macor JE..  (2013)  Potential CRF1R PET imaging agents: 1-fluoroalkylsubstituted 5-halo-3-(arylamino)pyrazin-2(1H)-ones.,  23  (7): [PMID:23465610] [10.1016/j.bmcl.2013.02.009]

Source